Help
RSS
API
Feed
Maltego
Contact
Domain > gulf.thenextbreath.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2021-04-26
104.93.21.152
(
ClassC
)
2021-08-15
184.25.237.162
(
ClassC
)
2024-09-30
18.161.6.127
(
ClassC
)
Port 80
HTTP/1.1 301 Moved PermanentlyServer: CloudFrontDate: Mon, 30 Sep 2024 03:31:33 GMTContent-Type: text/htmlContent-Length: 167Connection: keep-aliveLocation: https://gulf.thenextbreath.com/X-Cache: Redirect from cloudfrontVia: 1.1 0a166b53605851fe961f5a2952e5a748.cloudfront.net (CloudFront)X-Amz-Cf-Pop: HIO52-P1X-Amz-Cf-Id: VA5XPXq0IbkwH4dsdzoz-nxFdUp51xX6tF38XfzM9KshuIz4jRLgFw html>head>title>301 Moved Permanently/title>/head>body>center>h1>301 Moved Permanently/h1>/center>hr>center>CloudFront/center>/body>/html>
Port 443
HTTP/1.1 200 OKContent-Type: text/html; charsetUTF-8Content-Length: 181064Connection: keep-aliveDate: Mon, 30 Sep 2024 03:31:33 GMTServer: AmazonS3Last-Modified: Fri, 27 Oct 2023 04:47:35 GMTx-amz-version-id: ezW5I_d0t7EspquQCEQMvHDxEdDcrQvgETag: bcbe6698a69f4396b08ab77ee148cc97X-Frame-Options: DENYContent-Security-Policy-Report-Only: default-src self; report-uri https://csp.apache-static-test.sanofi-infra.com/csp-report-ems-prod.phpCache-Control: no-cacheExpires: 0Strict-Transport-Security: max-age31536000; includeSubDomainsX-Content-Type-Options: nosniffWWW-Authenticate: BasicVary: Accept-EncodingX-Cache: Miss from cloudfrontVia: 1.1 c28e01aa413e9ea602538ccda1511062.cloudfront.net (CloudFront)X-Amz-Cf-Pop: HIO52-P1X-Amz-Cf-Id: L6tOqpMAOaRZrLv-_9Bxhlhg6trlHfJyvJrAG0Nv3wYWaqnatieDbw !DOCTYPE html>html langen>head> meta charsetutf-8> meta http-equivX-UA-Compatible contentIEedge> meta nameviewport contentwidthdevice-width, initial-scale1> title>Future of Asthma | The Next Breath/title> meta propertyog:title contentThe Future of Asthma Is You | The Next Breath /> meta propertyog:description contentSevere asthma is too often overlooked. Learn about the signs and new science to help empower better asthma control. /> meta namedescription contentWhat is severe asthma? Discover its signs and impact, current barriers to better control, and the latest research on the role of Type 2 inflammation. /> meta namerobots contentINDEX, FOLLOW /> meta http-equivcontent-language contenten /> meta http-equivcontent-type contenttext/html;charsetUTF-8 /> meta http-equivlast-modified content2020-10-27@00:00:00 Z /> link relcanonical href/ /> meta propertyog:url contenthttps://gulf.thenextbreath.com/ /> script srcareas/globalcomponents/js/app_insight_monitoring.js typetext/javascript>/script> meta propertyog:site_name contentwww.thenextbreath.com> meta nametwitter:card contentsummary /> meta nametwitter:site contentwww.thenextbreath.com> meta nametwitter:title contentThe Future of Asthma Is You | The Next Breath> meta nametwitter:description contentSevere asthma is too often overlooked. Learn about the signs and new science to help empower better asthma control.> meta nametwitter:player contentwww.thenextbreath.com> !-- Adding jquery from CDN --> !if gte IE 9> script srchttps://cdnjs.cloudflare.com/ajax/libs/jquery/2.1.1/jquery.min.js typetext/javascript>/script> !endif> !--if lte IE 8> script srchttps://cdnjs.cloudflare.com/ajax/libs/jquery/1.8.3/jquery.min.js>/script> !endif--> !-- Bootstrap core CSS --> link hrefresources/css/site/fa4f300fe6cb42a3966a620815d66ea0.css@u20210308065308.css relstylesheet> /link> link hrefresources/css/page/81d6185a780e4dd4aa06e4931824d50c.css@u20210203083107.css relstylesheet> /link> script srcareas/globalcomponents/js/modernizr.min.js>/script> !--script>document.cookie + screen.width + ; path/; /script>--> !-- HTML5 shim and Respond.js IE8 support of HTML5 elements and media queries --> !--if lt IE 9> script src//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.7.2/html5shiv.min.js>/script> script src//cdnjs.cloudflare.com/ajax/libs/respond.js/1.4.2/respond.js>/script> !endif-->/head>body classhome> !-- Google Tag Manager --> script> (function(w, d, s, l, i) { wl wl || ; wl.push({ gtm.start: new Date().getTime(), event: gtm.js }); var f d.getElementsByTagName(s)0, j d.createElement(s), dl l ! dataLayer ? &l + l : ; j.async true; j.src https://www.googletagmanager.com/gtm.js?id + i + dl; f.parentNode.insertBefore(j, f); })(window, document, script, dataLayer, GTM-KFT5SSC); /script> !-- End Google Tag Manager --> !-- Google Tag Manager (noscript) --> noscript>iframe srchttps://www.googletagmanager.com/ns.html?idGTM-KFT5SSC height0 width0 styledisplay:none;visibility:hidden>/iframe>/noscript> !-- End Google Tag Manager (noscript) --> header> div classscore-header-wrapper> div classscore-header> div classcookie-component> noscript> div classunsupported-browser-div> You need to enable JavaScript in Your browser /div> /noscript> !--if lt IE 9> div classunsupported-browser-div > p>You are using an strong>outdated/strong> browser. Please a hrefhttp://browsehappy.com/>upgrade your browser/a> to improve your experience./p> /div> !endif--> !--if gt IE 8 | !IE !--> div iddivCookiclose classcookie-div hide-cookie> p classcook_content stylez-index: 1;>This website uses cookies, some of which may require your prior approval. By clicking ‘yes’ you agree to the use of these specific cookies. For more information, please review our Cookie Policy./p> a hrefjavascript:void(0) idbtnCookieClose classcookie-close>Yes, I accept cookies/a> /div> !-- !endif--> /div> /div> /div> /header> div classscore-structural score-column> div classscore-center> nav id classnavbar yamm navbar-default score-megamenu rolenavigation> div classscore-nav-wrapper> div classscore-nav> !-- score-nav-wrapper is the container --> div classnavbar-header score-navbar-header> button typebutton data-togglecollapse data-target#e2d68109-d259-48cb-9d77-7461b3c8371a classscore-hamburger navbar-toggle> span classicon-bar>/span> span classicon-bar>/span> span classicon-bar>/span> /button> a href/ classnavbar-brand> img src-/media/ems/conditions/genzyme/brands/dupixent-uae/the-next-breath-logo.png@h66&laen-gb&w303&hash6fe8981e0608ad75587361ed375869d085a41858 altUnderstanding Severe Asthma | The Next Breath width303 height66 /> /a> /div> div classcollapse navbar-collapse ide2d68109-d259-48cb-9d77-7461b3c8371a> ul classnav navbar-nav> li classscore-megamenu-basic-item>a href#Get-involved classGet-involved>GET INVOLVED/a>/li> li classscore-megamenu-basic-item>a href#Barriers-to-control classBarriers-to-control>BARRIERS TO CONTROL/a>/li> li classscore-megamenu-basic-item>a href#Severe-asthma classSevere-asthma>SEVERE ASTHMA/a>/li> li classscore-megamenu-basic-item>a href#New_science classNew_science>NEW SCIENCE/a>/li> li classscore-megamenu-basic-item>a hrefnasal-polyps>I HAVE NP/a>/li> li classscore-megamenu-basic-item>a hrefi-have-asthma classI_HAVE_ASTHMA>I HAVE ASTHMA/a>/li> li classscore-megamenu-basic-item>a hrefhttps://www.thenextbreath-arabic.com/ classlangselect-ar text_asthma3>العربية/a>/li> /ul> /div> /div> /div> /nav> /div> /div> div classpageWrapper> div classscore-container> div classcontainer> div classscore-page score-column1> div classscore-main> div classscore-inner> div classtext-component> div classlungs-text-wrap dirrtl styleposition: relative; display: block; max-width: 1366px;> style> @media screen and (max-width: 768px) { .lungs-text-wrap .next_content_wrap { width: 100% !important; right: auto !important; } .pageWrapper .score-container:first-child { height: 700px !important; } } * { outline: 0; outline: none; } .lungs-text-wrap #vjs_video_3 { position: absolute; top: 0px; left: 0px; width: 100%; height: 100%; } .lungs-text-wrap #vjs_video_3 .vjs-control-bar { display: none; } .lungs-text-wrap #vjs_video_3 .vjs-tech { pointer-events: none; } .lungs-text-wrap .next_content_wrap { position: absolute; top: 10%; right: 10%; width: 32%; } .servere_asthma .modal_wrap_vid .modal-body .vid_common { width: 100%; height: 100%; display: inline-block; padding: 5%; } div#vjs_video_855, div#vjs_video_506 { width: 100%; height: 100%; position: absolute; top: 0px; left: 0px; } .tammy_content.vid_common>div:first-child, .lynn_content.vid_common>div:first-child { position: relative; display: block; /* max-width: 100% !important; */ width: 100%; height: 100%; margin: 0 auto; } /style> !-- div classlungs_video> div classlungs_animate styleposition: relative; display: block; max-width: 1366px;>div stylepadding-top: 56.25%;>video data-video-id5997442913001 data-account5186843675001 data-player7J03vmW25 data-embeddefault data-application-id classvideo-js controls styleposition: absolute; top: 0px; right: 0px; bottom: 0px; left: 0px; width: 100%; height: 100%;>/video> /div>/div> --> div classlungs_video> div classlungs_animate> div stylepadding-top: 65.25%;> video classvideo-js vjs-fluid data-account3845398857001 data-playerdefault data-embeddefault autoplay loop data-video-id6146236661001 data-playlist-id data-application-id data-setup{ controls: false, autoplay: true, preload: auto, loop: true}>/video> /div> /div> div classnext_content_wrap> div classfuture_heading> h1> THE FUTURE OFbr classbreak_only> ASTHMA IS YOU /h1> p classp1_content> Use your next breath to drive /p> div classrolling_content> div classspinny-wrapper> h1 stylez-index: 1;> span classspinny-words styletext-align:right !important;> span>AWARENESS/span> span>SUPPORT/span> span>SCIENCE/span> span>EMPOWERMENT/span> span>ACTION/span> /span> /h1> /div> /div> /div> div classnext_breath_para> p classp1_content> The Next Breath aims to bring more awareness to strong>severe asthma,/strong> illuminate the strong>latest science/strong> and empower people tostrong> take action/strong> to strive towards better asthma control. /p> a href#Get-involved classbtn_content idGet-startlink>strong>GET STARTED/strong>/a> a href#Get-involved idGet-startlink> img classdown_arrow visible-lg visible-md src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/9,-d-, final images/desktop-homepage/downward-arrow> img classdown_arrow visible-sm visible-xs src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/mobile images/downward-arrow> /a> /div> /div> /div> /div> /div> /div> /div> /div> /div> /div> div classscore-container> div classcontainer> div classscore-page score-column1> div classscore-main> div classscore-inner> div classtext-component> div classget_started idGet-involved> div classget_started_wrap> div classget_started_heading > h2 stylez-index: 1;>strong classchange_col>The Next Breath/strong> is forbr classbreak_only> strong classchange_col>everyone /strong> with a role to play br classbreak_only> in building a brighter future for br classbreak_only> people with severe asthma: /h2> /div> div classget_started_content visible-lg visible-md> div classrow> div classcol-lg-4> div classget_frist_wrap mid_content> div classclm_content> img alt classfirst_img common_img src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop-homepage/section1-a> h3 classside_content stylez-index: 1;>I HAVE ASTHMA, ORbr classbreak_only> HAVE A LOVED ONEbr classbreak_only> WHO DOES/h3> /div> div classasthma_para common_line> p classp2_content stylez-index: 1;>Up to strong>50%/strong> of people overestimate how br classbreak_only>well-controlled their asthma is.sup>iv/sup> br classbreak_only>Could this be you or your loved one?/p> /div> div classget_first_btn first_btn> a classbtn_content hrefi-have-asthma target_blank>RETHINK YOUR ASTHMA WITH US/a> /div> /div> /div> div classcol-lg-4> div classget_frist_wrap left_content> div classclm_content> img alt classsec_img common_img src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/9,-d-, final images/desktop-homepage/01 the next breath/section1-b> h3 classside_content stylez-index: 1;>I’M AN ADVOCATE,br classbreak_only> MEMBER OF THE MEDIA,br classbreak_only> OR SIMPLY WANT TObr classbreak_only> FIND OUT MORE/h3> /div> div classadvocate_para common_line> p classp2_content stylez-index: 1;>Up to strong>35 million/strong> people worldwide livebr classbreak_only> with severe asthma symptoms.sup>i,ix/sup>br classbreak_only> So why is awareness still so low?/p> /div> div classget_first_btn second_btn> a classbtn_content learn-more-scroll href#Barriers-to-control>LEARN MORE TODAY/a> /div> /div> /div> div classcol-lg-4> div classget_frist_wrap right_content> div classclm_content> img classthird_img common_img alt src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/9,-d-, final images/desktop-homepage/01 the next breath/section1-c> h3 classside_content stylez-index: 1;>IM A HEALTHCAREbr classbreak_only> PROVIDER WHO br classbreak_only>TREATS ASTHMA/h3> /div> div classhealthcare_para common_line> p classp2_content stylez-index: 1;>Less thanstrong> 20%/strong> of patients discuss how asthmabr classbreak_only> impacts their life with their doctor.sup>ii/sup>br classbreak_only> Are you getting the full story?/p> /div> div classget_first_btn third_btn> a classbtn_content hrefi-treat-asthma target_blank>GUIDE YOUR PATIENTS TO OPEN UP/a> /div> /div> /div> /div> /div> /div> div classcarousel_get_started> div idowl_for_get_started classowl-carousel owl-theme owl_get_mob visible-sm visible-xs> div classowl-stage-outer> div classowl-stage> div classowl-item> div classitem> div classget_frist_wrap mid_content> div classclm_content> img alt classvisible-sm visible-xs src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/mobile-homepage/section-1-icon-2> h3 classside_content stylez-index: 1;>I’M AN ADVOCATE,br classbreak_only> MEMBER OF THE MEDIA,br classbreak_only> OR SIMPLY WANT TObr classbreak_only> FIND OUT MORE/h3> /div> div classadvocate_para commmon_para> p classp2_content stylez-index: 1;>Up to strong>35 million/strong> people worldwide livebr classvisible-md visible-lg> with severebr classvisible-sm visible-xs> asthma symptoms.br classbreak_only> So why is awareness still so low?/p> /div> div classget_first_btn second_btn> a classbtn_content href#Barriers-to-control>LEARN MORE TODAYimg classspac_btwn visible-xs visible-sm alt src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/mobile images/button-arrow>/a> /div> /div> /div> /div> div classowl-item > div classitem> div classget_frist_wrap left_content> div classclm_content> img alt classvisible-sm visible-xs src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/mobile-homepage/section-1-icon-1> h3 classside_content stylez-index: 1;>I HAVE ASTHMA, ORbr classbreak_only> HAVE A LOVED ONE WHO DOES/h3> /div> div classasthma_para commmon_para> p classp2_content stylez-index: 1;>Up to strong>50%/strong> of people overestimate how br classbreak_only>well-controlled their asthma is. br classbreak_only>Could this be you or your loved one?/p> /div> div classget_first_btn first_btn> a classbtn_content hrefi-have-asthma target_blank>RETHINK YOUR ASTHMA WITH USimg classspac_btwn visible-xs visible-sm alt src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/mobile images/button-arrow>/a> /div> /div> /div> /div> div classowl-item > div classitem> div classget_frist_wrap right_content> div classclm_content> img classvisible-sm visible-xs alt src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/mobile-homepage/section-1-icon-3> h3 classside_content stylez-index: 1;>IM A HEALTHCAREbr classbreak_only> PROVIDER WHO br classbreak_only>TREATS ASTHMA/h3> /div> div classhealthcare_para commmon_para> p classp2_content stylez-index: 1;>Less thanstrong> 20%/strong> of patients discuss how asthmabr classbreak_only> impacts their life with their doctor.br classbreak_only> Are you getting the full story?/p> /div> div classget_first_btn third_btn> a classbtn_content hrefi-treat-asthma target_blank>GUIDE YOUR PATIENTS TO OPEN UPimg classspac_btwn visible-xs visible-sm alt src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/mobile images/button-arrow>/a> /div> /div> /div> /div> /div> /div> /div> div classowl-nav-get nav_common visible-sm visible-xs> div classowl-prev-getst btn_nav>img alt src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop - patient and hcp patients/arrow-left classprev_btn>/div> div classowl-next-getst btn_nav>img alt src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop - patient and hcp patients/arrow-right classnext_btn>/div> /div> /div> /div> /div> /div> /div> /div> /div> /div> div classscore-container> div classcontainer> div classscore-page score-column1> div classscore-main> div classscore-inner> div classtext-component> div classbarriers_control idBarriers-to-control> div classbarriers_control_wrap> div classbarriers_wrap> div classrow> div classcol-sm-4> div classclm_content> div classbarriers_heading> h2 stylez-index: 1;>What can stand br classbreak_only>in the way of betterbr classbreak_only> asthma control?/h2> /div> div classp2_content> p classbarriers_first_para p2_content stylez-index: 1;>strong>Awareness of barriers will help usbr classbreak_only> to tackle them better together./strong> /p> p classbarriers_sec_para p2_content stylez-index: 1;> As many as strong>45% /strong>of people living with asthmabr classbreak_only> have symptoms that are not well-controlled.sup>ii/sup>br classbreak_only> Different barriers can prevent people from br classbreak_only>achieving better asthma control, andbr classbreak_only> everyone can play a role in addressing them. /p> p classp2_content visible-sm visible-xs> Get informed about these barriers here,br classbreak_only> then read on to learn about severe asthma,br classbreak_only> a form of asthma that can be particularlybr classbreak_only> difficult to control. /p> /div> /div> /div> div classcol-sm-8 visible-lg visible-md> div classbarriers_content_wrap> div classbarriers_pics_wrap barriers_common_parent> div classpatient_doc shake_icon barriers_common idone> img src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/9,-d-, final images/desktop-homepage/02 better asthma control/section2-a> h3 stylez-index: 1;>Patient-Doctor br classbreak-only> Disconnects/h3> /div> div idtwo classnational_policy barriers_common shake_icon> img src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/9,-d-, final images/desktop-homepage/02 better asthma control/section2-f> h3 stylez-index: 1;>National br classbreak-only>Policies/h3> /div> div idthree classoverlook_sym barriers_common shake_icon> img src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/9,-d-, final images/desktop-homepage/02 better asthma control/section2-e> h3 stylez-index: 1;>Overlooking br classbreak-only>Symptoms/h3> /div> div idfour classsocial_misper barriers_common shake_icon> img src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/9,-d-, final images/desktop-homepage/02 better asthma control/section2-b> h3 stylez-index: 1;>Societal br classbreak-only> Misperceptions/h3> /div> div idfive class treat_appro barriers_common shake_icon> img src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/9,-d-, final images/desktop-homepage/02 better asthma control/section2-c> h3 stylez-index: 1;>Treatment br classbreak-only>Approaches/h3> /div> div idsix classaccess_special barriers_common shake_icon> img src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/9,-d-, final images/desktop-homepage/02 better asthma control/section2-d> h3 stylez-index: 1;>Access to br classbreak-only>Specialists/h3> /div> /div> div classwrap_content_barr> p classp2_content patient_doc_par one stylez-index: 1;> People with asthma and doctors can br classbreak_only>have different ways of talking aboutbr classbreak_only> how well-controlled asthma is, and in br classbreak_only>one study, almost strong>20%/strong> of people br classbreak_only>hadnt discussed their symptoms with br classbreak_only>a doctor at all. sup>v/sup> /p> p classp2_content national_policy_par two stylez-index: 1;> There are few standalone national br classbreak_only>policies that are focused on a holisticbr classbreak_only> approach to reducing the burden ofbr classbreak_only> asthma, from awareness to br classbreak_only>environmental risk factor prevention tobr classbreak_only> treatment decisions. /p> p classp2_content overlook_sym_par three stylez-index: 1;> It is easy for a person to overlook howbr classbreak_only> serious their asthma really is. In onebr classbreak_only> study, up to strong>50%/strong> of people reportingbr classbreak_only> severe symptoms considered theirbr classbreak_only> asthma to be completely or br classbreak_only>well-controlled.sup>iv/sup> /p> p classp2_content social_misper_par four stylez-index: 1;> When others misunderstand what causes br classbreak_only>asthma and how serious it canbr classbreak_only> be, it can create an environment that is notbr classbreak_only> supportive. In one study, strong>87.5%/strong> hadbr classbreak_only> experienced stigma about their asthma; inbr classbreak_only> another, more than strong>25%/strong> reported feeling br classbreak_only>embarrassed about their asthma medicines.sup>xi/sup> /p> p classp2_content treat_appro_par five stylez-index: 1;> Many people rely on quick-relief medicines,br classbreak_only> which can ease symptoms in the momentbr classbreak_only> but do not adequately address their cause.br classbreak_only> In one survey, strong>23%/strong> of people using thesebr classbreak_only> medicines needed urgent asthma treatmentbr classbreak_only> in the past year and almost strong>70%/strong> still had br classbreak_only>poorly controlled symptoms.sup>viii/sup> /p> p classp2_content access_special_par six stylez-index: 1;> Asthma specialists (allergists,br classbreak_only> pulmonologists) are more likely to be upbr classbreak_only> to date on the latest science andbr classbreak_only> treatment approaches, but strong>48%/strong> of people br classbreak_only>with asthma have never visited one. sup>vi/sup> /p> p classp2_content common_para active stylez-index: 1;> Get informed about these barriers here,br classbreak_only> then read on to learn about severe asthma,br classbreak_only> a form of asthma that can be particularlybr classbreak_only> difficult to control. /p> /div> div>a hrefhttps://twitter.com/search?q%23TheNextBreath stylecolor: #00aeef; font-size: 14px;> Follow us on #TheNextBreath/a> /div> /div> /div> /div> div classcarousel_barriers> div idmob_barriers classowl-carousel owl-theme visible-sm visible-xs> div classitem> div classsocial_miscerp_wrap mob_bar > div classsocial_misper img_com> img src~%255cmedia%255cd17a2310b30f4e52a43ba2fcf12a2a1a> h3 stylez-index: 1;>Societal br classbreak-only> Misperceptions/h3> /div> div classsocial_misper_par> p classp2_content four stylez-index: 1;> When others misunderstand what causes br classbreak_only>asthma and how serious it canbr classbreak_only> be, it can create an environment that is notbr classbreak_only> supportive. In one study, strong>87.5%/strong> hadbr classbreak_only> experienced stigma about their asthma; inbr classbreak_only> another, more than strong>25%/strong> reported feeling br classbreak_only>embarrassed about their asthma medicines.sup>xi/sup> /p> /div> div>a hrefhttps://twitter.com/search?q%23TheNextBreath stylecolor: #00aeef; font-size: 14px;> Follow us on #TheNextBreath/a> /div> /div> /div> div classitem> div classtreat_appro_wrap mob_bar mob_aft> div class treat_appro img_com> img src~%255cmedia%255c9f6e5ec71d774b6cbe1a303968179058> h3 stylez-index: 1;>Treatment br classbreak-only>Approaches/h3> /div> div classtreat_appro_par> p classp2_content five stylez-index: 1;> Many people rely on quick-relief medicines,br classbreak_only> which can ease symptoms in the momentbr classbreak_only> but do not adequately address their cause.br classbreak_only> In one survey, strong>23%/strong> of people using thesebr classbreak_only> medicines needed urgent asthma treatmentbr classbreak_only> in the past year and almost strong>70%/strong> still had br classbreak_only>poorly controlled symptoms.sup>viii/sup> /p> /div> div>a hrefhttps://twitter.com/search?q%23TheNextBreath stylecolor: #00aeef; font-size: 14px;> Follow us on #TheNextBreath/a> /div> /div> /div> div classitem> div classaccess_spl_wrap_wrap mob_bar mob_aft> div classaccess_special img_com> img src~%255cmedia%255c564b5b3aaa854c7a9a87505e099d2f54> h3 stylez-index: 1;>Access to br classbreak-only>Specialists/h3> /div> div classaccess_special_par> p classp2_content six stylez-index: 1;> Asthma specialists (allergists,br classbreak_only> pulmonologists) are more likely to be upbr classbreak_only> to date on the latest science andbr classbreak_only> treatment approaches, but strong>48%/strong> of people br classbreak_only>with asthma have never visited one. /p> /div> div>a hrefhttps://twitter.com/search?q%23TheNextBreath stylecolor: #00aeef; font-size: 14px;> Follow us on #TheNextBreath/a> /div> /div> /div> div classitem> div classover_look_wrap mob_bar mob_aft> div classoverlook_sym img_com> img src~%255cmedia%255c3bb3c91ab0d04fe8ab9a3599e7ff9e0c> h3 stylez-index: 1;>Overlooking br classbreak-only>Symptoms/h3> /div> div classoverlook_sym_par> p classp2_content three stylez-index: 1;> It is easy for a person to overlook howbr classbreak_only> serious their asthma really is. In onebr classbreak_only> study, up to strong>50%/strong> of people reportingbr classbreak_only> severe symptoms considered theirbr classbreak_only> asthma to be completely or br classbreak_only>well-controlled. /p> /div> div>a hrefhttps://twitter.com/search?q%23TheNextBreath stylecolor: #00aeef; font-size: 14px;> Follow us on #TheNextBreath/a> /div> /div> /div> div classitem> div classpatient_doc_wrap mob_bar mob_aft > div classpatient_doc img_com> img src~%255cmedia%255c6814d23d5ebd4e039fb006e0a328b322> h3 stylez-index: 1;>Patient-Doctor br classbreak-only> Disconnects/h3> /div> div classpatient_doc_par> p classp2_content one stylez-index: 1;> People with asthma and doctors can br classbreak_only>have different ways of talking aboutbr classbreak_only> how well-controlled asthma is, and in br classbreak_only>one study, almost strong>20%/strong> of people br classbreak_only>hadnt discussed their symptoms with br classbreak_only>a doctor at all. /p> /div> div>a hrefhttps://twitter.com/search?q%23TheNextBreath stylecolor: #00aeef; font-size: 14px;> Follow us on #TheNextBreath/a> /div> /div> /div> div classitem> div classnational_pol_wrap mob_bar mob_aft > div classnational_policy img_com> img src~%255cmedia%255cc9fcd269c8774c778f2f9ec429b52f1f> h3 stylez-index: 1;>National br classbreak-only>Policies/h3> /div> div classnational_policy_par> p classp2_content two stylez-index: 1;> There are few standalone national br classbreak_only>policies that are focused on a holisticbr classbreak_only> approach to reducing the burden ofbr classbreak_only> asthma, from awareness to br classbreak_only>environmental risk factor prevention tobr classbreak_only> treatment decisions. /p> /div> div>a hrefhttps://twitter.com/search?q%23TheNextBreath stylecolor: #00aeef; font-size: 14px;> Follow us on #TheNextBreath/a> /div> /div> /div> div classowl_nav_bt nav_common visible-sm visible-xs> div classowl-prev-barriers btn_nav>img alt src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop - patient and hcp patients/arrow-left classprev_btn>/div> div classowl-next-barriers btn_nav>img alt src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop - patient and hcp patients/arrow-right classnext_btn>/div> /div> /div> /div> div classback_wrap> div classback_content> div classback_heading> h2 stylez-index: 1;>Are you living br classbreak_only>with asthma?/h2> /div> div classback_para> p classp2_content stylez-index: 1;>Your condition may not be as well-controlled as youbr classbreak_only> think it is. Check out these tools to help you rethink yourbr classbreak_only> asthma and take back control of your condition. /p> a classbtn_content hrefi-have-asthma target_blank>CHECK OUT OUR TOOLS/a> /div> /div> /div> /div> /div> /div> /div> /div> /div> /div> /div> /div> div classscore-container> div classcontainer> div classscore-page score-column1> div classscore-main> div classscore-inner> div classtext-component> div classservere_asthma idSevere-asthma> div classsevere_wrap> div classrow> div classcol-sm-6> div classsevere_asthma_content> h3 classh3-styling stylez-index: 1;>What is severe asthma?/h3> div classp2_content>strong>Its time to bring more awareness to the condition and its impact./strong>/div> div classfirst_para> p classp2_content stylez-index: 1;>Each persons asthma is experienced differently and can vary in its symptoms,br classbreak_only> severity and the treatment required. Many people with asthma can effectivelybr classbreak_only> manage their condition with controller medicines. /p> /div> div class second_para> p classp2_content stylez-index: 1;>However,strong> 5% to 10% of asthma cases are classified as severe/strong>sup>ix/sup> and can be harder to control, disrupting day-to-day lives even when multiple controllerbr classbreak_only> medicines are used. Severe asthma that isnt well-controlled is also known asbr classbreak_only> uncontrolled or persistent asthma.sup>x/sup>/p> /div> div classthird_para> p classp2_content stylez-index: 1;>Despite this impact, severe asthma often goes unrecognized. People with severe br classbreak_only> asthma may not realize that their asthma falls into this category - and people who br classbreak_only> don’t have the condition may not realize how serious it can be. With new sciencebr classbreak_only> expanding possibilities for life with severe asthma, its more important than ever to br classbreak_only> increase awareness of the symptoms and the impact of the condition./p> /div> /div> /div> div classcol-sm-6 > div classpopup_wrap> div classsymptoms_popup asthma_com> img classsym_log src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/section3-a> img src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/plus-button data-togglemodal data-target#symptom_myModal classsym_plus plus_com> /div> div idsymptom_myModal classmodal fade in roledialog aria-hiddentrue styledisplay: none;> div classmodal-dialog common_modal> !-- Modal content--> div classmodal-content comon_con> div classmodal-header> button typebutton classclose data-dismissmodal> img alt src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop-homepage/close-button>/button> /div> div classsymptom_modal-body> h2 classsym_head stylez-index: 1;>Symptoms/h2> div classp2_content first_para> p classp2_content stylez-index: 1;>People living with severe asthma experience symptoms as part of everyday life, despite the use of multiple medicines, and are at risk for life-threatening asthma attacks that can require emergency hospitalizations.sup>x,xi/sup>/p> /div> div classp2_content> p classp2_content stylez-index: 1;>strong>Severe asthma can be recognized by experiencing symptoms, such as coughing, wheezing and br>difficulty breathing:sup>xii/sup>/strong>/p> /div> div classsymptoms_content> div classrow> div classcol-md-6> div classsymptoms_two > div classsym_first_par one_side_common> img classcough_symbol src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/9,-d-, final images/desktop-homepage/03 what is severe asthma/pop-outs/symtoms-icon-a> p classp2_content stylez-index: 1;>strong>More thanbr classbreak_only> 2x a week/strong>/p> /div> div classsym_secon_par one_side_common> img classbed_symbol src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/9,-d-, final images/desktop-homepage/03 what is severe asthma/pop-outs/symtoms-icon-b> p classp2_content stylez-index: 1;>strong>That interrupt br classbreak_only>sleep at night/strong>/p> /div> /div> /div> div classcol-md-6> div classsymptoms_one > img src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/9,-d-, final images/desktop-homepage/03 what is severe asthma/pop-outs/symtoms-icon-c classsym_one_im> p classp2_content stylez-index: 1;>strong>That restrict daily activity, such as sports,br classbreak_only> socializing and going outside/strong>/p> /div> /div> /div> div classsymptoms_zero > img classsym_rescue src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop-homepage/section2-c> p classp2_content stylez-index: 1;>strong>People living with severe asthma may also have to usebr classbreak_only> quick-relief “rescue” inhalers more than 2x a week./strong>/p> /div> p classp2_content sym_last_par stylez-index: 1;> It is easy for a person to overlook the severity of their asthma, and in some cases, experiencing everyday symptoms can start to feel normal. /p> /div> /div> div classmodal-footer> div classsocial_content> div>a hrefhttps://twitter.com/search?q%23TheNextBreath stylecolor: #00aeef; font-size: 14px;> Follow us on #TheNextBreath/a> /div> /div> /div> /div> /div> /div> div classasthma_com societal_popup> img src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/section3-b classsocietal_log> img src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/plus-button data-togglemodal data-target#soc_myModal classsocietal_plus plus_com> /div> div idsoc_myModal classmodal fade in roledialog aria-hiddentrue styledisplay: none;> div classmodal-dialog common_modal> !-- Modal content--> div classmodal-content common_con> div classmodal-header> button typebutton classclose data-dismissmodal> img alt src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop-homepage/close-button> /button> /div> div classsocietal_modal-body> div classsocietal_wrap_con> !--div classsoc_back_mob visible-sm visible-xs>img src~/media/76595EC14D334E82BF1A8C086835FC1B classonly_mob>/div>--> div classsoc_back_mob visible-sm visible-xs>img src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/mobile images/mobile-societal-impact-image classonly_mob>/div> div classsoc_con_war> h2 classsoc_head stylez-index: 1;>Societal Impact/h2> div classp2_content > p classp2_content stylez-index: 1;>strong>The societal and economic impact of asthma is often underestimated./strong>/p> /div> div classsoc_paras> ul typecircle> li stylez-index: 1;> p classp2_content first_paras stylez-index: 1;> Asthma is associated with both direct costs, in the form of healthcarebr classbreak_only> needs like hospitalizations and medications, and indirect costs, in thebr classbreak_only> form of missed days of work or lower productivity. Combined, thesebr classbreak_only> have been estimated to cost strong>€34/strong> billion in Europe alone each year.sup>xix/sup> /p> /li> li stylez-index: 1;> p classp2_content sec_paras stylez-index: 1;> The long-term use of asthma medicines known as oral corticosteroids br classbreak_only>can cause serious side effects, such as cataracts, osteoporosis and br classbreak_only> diabetes, which also have to be managed, placing considerable pressure br classbreak_only>on healthcare systems worldwide.sup>xx/sup> /p> /li> li stylez-index: 1;> p classp2_content third_paras stylez-index: 1;> Severe asthma makes upstrong> 5% /strong>to strong>10% /strong>of asthma cases,sup>ix/sup> but strong>50% /strong> of br classbreak_only>associated healthcare costs.sup>xxi/sup> The costs associated with severe asthmabr classbreak_only> can be strong>more than 2x/strong> those of well-controlled asthma.sup>xxii/sup> /p> /li> /ul> /div> div classsocial_content> div>a hrefhttps://twitter.com/search?q%23TheNextBreath stylecolor: #00aeef; font-size: 14px;> Follow us on #TheNextBreath/a> /div> /div> /div> /div> /div> /div> /div> /div> div classasthma_com personal_popup> img classpersonal_log src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/section3-c> img src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/plus-button data-togglemodal data-target#personal_myModal classpersonal_plus plus_com> /div> div idpersonal_myModal classmodal fade in roledialog aria-hiddentrue styledisplay: none;> div classmodal-dialog common_modal> !-- Modal content--> div classmodal-content common_con> div classmodal-header> button typebutton classclose data-dismissmodal> img alt src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop-homepage/close-button> /button> /div> div classpersonal_modal-body> h2 classperson_head stylez-index: 1;>Personal Impact/h2> div classpersonal_para> p stylez-index: 1; classp2_content>The symptoms of severe asthma that isn’tbr> well-controlled can be ever-present andbr> impact the everyday lives of those livingbr> with the condition and their loved ones./p> /div> div classperson_content_wrap visible-lg visible-md> div classpersonal_logos> div classpersonal_logo_one connect shake_icon idper_one> img src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop-homepage/personal-impact-physical> h3 stylez-index: 1;>Physical/h3> /div> div classpersonal_logo_two connect shake_icon idper_two> img src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop-homepage/personal-impact-emotional> h3 stylez-index: 1;>Emotional/h3> /div> div classpersonal_logo_three connect shake_icon idper_three> img src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop-homepage/personal-impact-social> h3 stylez-index: 1;>Social/h3> /div> div classpersonal_logo_four connect personal_active shake_icon idper_four> img src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop-homepage/personal-impact-work-school> h3 stylez-index: 1;>Work and br> School/h3> /div> div idper_five classpersonal_logo_five connect shake_icon> img src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop-homepage/personal-impact-family-home> h3 stylez-index: 1;>Family and br>Homelife/h3> /div> /div> div classpersonal_full_content> p classp2_content persona_par per_one stylez-index: 1;> Severe asthma can interfere withbr classbreak_only> physical activity and make routinebr classbreak_only> tasks like climbing stairs, doing choresbr classbreak_only> and running errands feel exhausting. sup>xiii/sup>In br classbreak_only>a recent survey, strong>97%/strong> of people livingbr classbreak_only> with severe asthma reported that theirbr classbreak_only> condition limited their everyday tasksbr classbreak_only> and strong>81%/strong> felt that their ability tobr classbreak_only> exercise was impacted.sup>xvi,xiv/sup> /p> p classp2_content persona_par per_two stylez-index: 1;> It is common for people with severebr classbreak_only> asthma to experience anxiety and panicbr classbreak_only> attacks due to the unpredictability of br classbreak_only>their symptoms, and it is estimated thatbr classbreak_only> strong>30%/strong> tostrong> 50%/strong> of individuals experience br classbreak_only>symptoms of depression.sup>xv/sup> /p> p classp2_content persona_par per_three stylez-index: 1;> In a recent survey, strong>83%/strong> said asthmabr classbreak_only> affected their personal relationships.sup>xvi/sup>br classbreak_only> The symptoms of severe asthma canbr classbreak_only> keep people from doing what they br classbreak_only>love with friends, and misperceptionsbr classbreak_only> about the condition can make peoplebr classbreak_only> feel misunderstood or embarrassed. sup>xvi,xi/sup> /p> p classp2_content persona_par per_four personal_active stylez-index: 1;> Severe asthma can cause people tobr classbreak_only> have lower productivity or missbr classbreak_only> school and work. In Europe, asthma br classbreak_only>contributes to strong>100 million/strong> lostbr classbreak_only> school and workdays each year. sup>xvii/sup> /p> p classp2_content persona_par per_five stylez-index: 1;> Severe asthma can cause anxietybr classbreak_only> among family members and friendsbr classbreak_only> regarding the health and safety ofbr classbreak_only> their loved one.sup>xviii/sup> In a recent survey,br classbreak_only>strong>49%/strong> of people living with severe br classbreak_only>asthma felt that their condition was abr classbreak_only> burden to their families. sup>xiv/sup> /p> /div> /div> div classcarousel_severe_personal> div idpersonal_severe classowl-carousel owl-theme visible-sm visible-xs> div classitem> div classfirst_personal_wrap > div classpersonal_logo_one connect idper_one> img src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop-homepage/personal-impact-physical> h3 stylez-index: 1;>Physical/h3> /div> div classphysical_para> p classp2_content persona_par per_one stylez-index: 1;> Severe asthma can interfere withbr classbreak_only> physical activity and make routinebr classbreak_only> tasks like climbing stairs, doing choresbr classbreak_only> and running errands feel exhausting.sup>xviii/sup> In br classbreak_only>a recent survey, strong>97%/strong> of people livingbr classbreak_only> with severe asthma reported that theirbr classbreak_only> condition limited their everyday tasksbr classbreak_only> and strong>81%/strong> felt that their ability tobr classbreak_only> exercise was impacted.sup>xvi,xiv/sup> /p> /div> /div> /div> div classitem> div classsecond_personal_wrap com_bef> div classpersonal_logo_two connect idper_two> img src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop-homepage/personal-impact-emotional> h3 stylez-index: 1;>Emotional/h3> /div> div classemotional_para> p classp2_content persona_par per_two stylez-index: 1;> It is common for people with severebr classbreak_only> asthma to experience anxiety and panicbr classbreak_only> attacks due to the unpredictability of br classbreak_only>their symptoms, and it is estimated thatbr classbreak_only> strong>30%/strong> tostrong> 50%/strong> of individuals experience br classbreak_only>symptoms of depression.sup>xv/sup> /p> /div> /div> /div> div classitem> div classthird_personal_wrap com_bef> div classpersonal_logo_three connect idper_three> img src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop-homepage/personal-impact-social> h3 stylez-index: 1;>Social/h3> /div> div classsocial_para> p classp2_content persona_par per_three stylez-index: 1;> In a recent survey, strong>83%/strong> said asthmabr classbreak_only> affected their personal relationships.sup>xvi/sup>br classbreak_only> The symptoms of severe asthma canbr classbreak_only> keep people from doing what they br classbreak_only>love with friends, and misperceptionsbr classbreak_only> about the condition can make peoplebr classbreak_only> feel misunderstood or embarrassed. sup>xvi,xi/sup> /p> /div> /div> /div> div classitem> div classfourth_personal_wrap com_bef> div classpersonal_logo_four connect personal_active idper_four> img src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop-homepage/personal-impact-work-school> h3 stylez-index: 1;>Work and br> School/h3> /div> div classwrk_school_para> p classp2_content persona_par per_four personal_active stylez-index: 1;> Severe asthma can cause people tobr classbreak_only> have lower productivity or missbr classbreak_only> school and work. In Europe, asthma br classbreak_only>contributes to strong>100 million/strong> lostbr classbreak_only> school and workdays each year. sup>xvii/sup> /p> /div> /div> /div> div classitem> div classfifth_personal_wrap com_bef> div idper_five classpersonal_logo_five connect > img src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop-homepage/personal-impact-family-home> h3 stylez-index: 1;>Family and br>Homelife/h3> /div> div classhomelife_para> p classp2_content persona_par per_five stylez-index: 1;> Severe asthma can cause anxietybr classbreak_only> among family members and friendsbr classbreak_only> regarding the health and safety ofbr classbreak_only> their loved one.sup>xviii/sup> In a recent survey, br classbreak_only>strong>49%/strong> of people living with severe br classbreak_only>asthma felt that their condition was abr classbreak_only> burden to their families.sup>xiv/sup> /p> /div> /div> /div> /div> div classowl-nav-severe nav_common visible-sm visible-xs> div classowl-prev-pers btn_nav>img alt src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop - patient and hcp patients/arrow-left classprev_btn>/div> div classowl-next-pers btn_nav>img alt src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop - patient and hcp patients/arrow-right classnext_btn>/div> /div> /div> div classsocial_content> div>a hrefhttps://twitter.com/search?q%23TheNextBreath stylecolor: #00aeef; font-size: 14px;> Follow us on #TheNextBreath/a> /div> /div> /div> /div> /div> /div> /div> /div> /div> /div> div classcarousel_wrap> div idvid_wrap_whole classowl-carousel owl-theme > /div> div classmodal_wrap_vid> div classmodal fade idlynn_modal roledialog> div classmodal-dialog> !-- Modal content--> !-- div classmodal-content> div classmodal-header> /div> div classmodal-body> div classlynn_content vid_common> div stylemax-width: 960px;>video classvideo-js vjs-fluid data-account3845398857001 data-playerdefault data-embeddefault controls data-video-id6148312180001 data-playlist-id data-application-id>/video>/div> /div> /div> div classmodal-footer> div classsocial_content> div>a hrefhttps://twitter.com/search?q%23TheNextBreath stylecolor: #00aeef; font-size: 14px;> Follow us on #TheNextBreath/a> /div> /div> /div> /div> /div> /div> div classmodal fade idtammy_modal roledialog> div classmodal-dialog> --> !-- Modal content--> !-- div classmodal-content> div classmodal-header> /div> div classmodal-body> div classtammy_content vid_common> div stylemax-width: 960px;>video classvideo-js vjs-fluid data-account3845398857001 data-playerdefault data-embeddefault controls data-video-id6148314743001 data-playlist-id data-application-id>/video>/div> /div> /div> div classmodal-footer> div classsocial_content> div>a hrefhttps://twitter.com/search?q%23TheNextBreath stylecolor: #00aeef; font-size: 14px;> Follow us on #TheNextBreath/a> /div> /div> /div> /div> --> /div> /div> /div> div classsevere_back> div classservere_content> div classsevere_head> h2 stylez-index: 1;>Are you living with, caring for,br classbreak_only > or treating someone with asthma?/h2> /div> div classback_para> p classp2_content stylez-index: 1;>Click for tools to help you have more productive conversations./p> /div> !-- a classbtn_content back_one href/i-have-asthma target_blank>I HAVE ASTHMA OR HAVE A LOVED ONE WHO DOES/a> a classbtn_content back_two href/i-treat-asthma target_blank> I TREAT ASTHMA/a> --> center>a classbtn_content back_one desktopcontent hrefi-have-asthma target_blank>I HAVE ASTHMA OR HAVE A LOVED ONE WHO DOES/a>/center> !--a classbtn_content back_two desktopcontent href/i-treat-asthma target_blank> I TREAT ASTHMA/a> a classbtn_content back_two mobilecontent href/i-treat-asthma target_blank> I TREAT ASTHMA/a> --> center>a classbtn_content back_one mobilecontent hrefi-have-asthma target_blank>I HAVE ASTHMA OR HAVE A LOVED ONE WHO DOES/a>/center> /div> /div> /div> /div> /div> /div> /div> /div> /div> /div> div classscore-container> div classcontainer> div classscore-page score-column1> div classscore-main> div classscore-inner> div classtext-component> div classnew_science idNew_science> div classnew_science_wrap> div classnew_sci_first> div classsci_head> h4 stylez-index: 1;>Where is the br classbreak_only>science heading?/h4> p classp2_content stylez-index: 1;>strong> More is known than ever before about thebr classbreak_only> science of severe asthma, opening up newbr classbreak_only> ways to manage the condition./strong> /p> /div> div classsci_side_content> div idside_one classcause_ast side_com science_common> img classfly_ri new_common visible-lg visible-md src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop-homepage/section4-a> img classfly_ri new_common visible-xs visible-sm src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/mobile images/section4-a> div classasthma_down opac_common>strong>CAUSES OF ASTHMA/strong>/div> /div> div idside_two classinflam_two side_com> img classfly_ri new_common visible-md visible-lg src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop-homepage/section4-b> img classfly_ri new_common visible-xs visible-sm src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/mobile images/section4-b> div classtype2_down opac_common>strong>TYPE 2br classbreak_only> INFLAMMATION/strong>/div> /div> div idside_three classfuture_scan side_com> img classfly_ri new_common visible-lg visible-md src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop-homepage/section4-c> img classfly_ri new_common visible-xs visible-sm src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/mobile images/section4-c> div classfuture_down opac_common>strong>FUTURE OF CARE/strong>/div> /div> /div> /div> div classnew_sci_second> div classcause_asthma_wrap new_science_full side_one on_page> div classcause_asthma_left asthma_full left_wrap_common> img classcause_of_asthma gif_new_common visible-lg visible-md src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop - gif files/tnb_causesofasthma_v2> img classcause_of_asthma gif_new_common visible-xs visible-sm src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/mobile- gif files/tnb_causesofasthma_v2_mobile> /div> div classcause_asthma_right asthma_full slide_content right_wrap_common> div classtop_head> h3 stylez-index: 1;>CAUSES OF ASTHMA /h3> div classnew_sci_social soc_common> div>a hrefhttps://twitter.com/search?q%23TheNextBreath stylecolor: #00aeef; font-size: 14px;> Follow us on #TheNextBreath/a> /div> /div> /div> div classcause_slide_one dummy_one slide_common scroll_common slide_content active> p classp2_content stylez-index: 1;> Asthma is a chronic condition that affects the br classbreak_only>airways. It is caused by two different sources: /p> ul typecircle> li stylez-index: 1;> p classp2_content stylez-index: 1;> strong>Immune System:/strong> An overactive immune system br classbreak_only>can cause inflammation in the airways, causing br classbreak_only>them to narrow and making it harder to breathe.sup>xxiii/sup> /p> /li> li stylez-index: 1;> p classp2_content stylez-index: 1;> strong>Environmental Triggers:/strong> Factors such as br classbreak_only>pollen, smoke, weather changes or exercise canbr classbreak_only> trigger this inflammation, causing the onset or br classbreak_only>worsening of asthma symptoms.sup>x/sup> /p> /li> /ul> /div> div classcause_slide_two slide_common slide_content scroll_common dummy_two > p classp2_content one_para stylez-index: 1;> Some people have asthma that is associated br classbreak_only>with obesity or aging; for others, the conditionbr classbreak_only> is associated with inflammation due tobr classbreak_only> problems with the immune system.sup>x/sup> /p> p classp2_content slide_two>Let’s take a closer look at a specific type ofbr classbreak_only> inflammation called type 2 inflammation./p> /div> div classnav_common_ast arr_new_com> div classowl-prev-ast btn_nav_arr enable>img alt src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/blue-arrow-left classprev_btn_blu>/div> div classowl-next-ast btn_nav_arr enable>img alt src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/blue-arrow-right classnext_btn_blu>/div> /div> div classdummy dum_com> ul classdummy_lt cir_com dot_com_parent> li iddummy_one classcir_com dot_com first_one dummy_col stylez-index: 1;>/li> li iddummy_two classcir_com dot_com second_one stylez-index: 1;>/li> /ul> /div> /div> /div> div classtype_inflammation_wrap inflammatin_full side_two new_science_full > div classtype_inflam_left inflammatin_full common_type2_parent left_wrap_common> div classasthma_patients common_type2 dummy_inflamone open> img src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop - gif files/tnb_percentasthmapatients_v2 classcommon_imge gif_new_common visible-lg visible-md > img src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/mobile- gif files/tnb_allergiceosinophilicasthma_v3_mobile classcommon_imge gif_new_common visible-xs visible-sm > /div> div classtype_two_inflam common_type2 dummy_inflamtwo> img classcommon_imge gif_new_common visible-md visible-lg src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop - gif files/tnb_whatistype2inflammation_v1> img classcommon_imge gif_new_common visible-xs visible-sm src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/mobile- gif files/tnb_fourgoalsofasthmacontrol_v1_mobile> /div> div classallergic_asthma common_type2 dummy_inflamthree> img classcommon_imge gif_new_common visible-lg visible-md src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop - gif files/tnb_allergiceosinophilicasthma_v3> img classcommon_imge gif_new_common visible-xs visible-sm src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/mobile- gif files/tnb_percentasthmapatients_v2_mobile> /div> div classcomorbidities_type common_type2 dummy_inflamfour> img classcommon_imge gif_new_common visible-lg visible-md src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop - gif files/tnb_type2inflammation-4_v1> img classcommon_imge gif_new_common visible-sm visible-xs src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/mobile- gif files/tnb_type2inflammation-4_v1_mobile> /div> /div> div classtype_inflam_right inflammatin_full com_content right_wrap_common> div classtop_head> h3 stylez-index: 1;>TYPE 2 INFLAMMATION /h3> div classnew_sci_social soc_common> div>a hrefhttps://twitter.com/search?q%23TheNextBreath stylecolor: #00aeef; font-size: 14px;> Follow us on #TheNextBreath/a> /div> /div> /div> div classpercent_content dummy_inflamone slide_common scroll_common com_content active> p classp2_content stylez-index: 1;> Through scientific advances in asthma biology,br classbreak_only> we now understand that a particular type of br classbreak_only>inflammation called strong>type 2 inflammation/strong> isbr classbreak_only> present in strong>50 to 70%/strong> of people with asthma.sup>xxiv,xv/sup> /p> /div> div classtypetwo_content dummy_inflamtwo slide_common scroll_common com_content> p classp2_content stylez-index: 1;> There are often higher levels of type 2br classbreak_only> inflammation in the airways of people with br classbreak_only>severe asthma.sup>xxiv/sup> Reducing this inflammation can br classbreak_only> help to control symptoms.sup>xxvii/sup> /p> /div> div classallergic_content dummy_inflamthree slide_common scroll_common com_content > p classp2_content stylez-index: 1;> Asthma described as “eosinophilic” or br classbreak_only>“allergic” (or a mixture of the two) hasbr classbreak_only> underlying type 2 inflammation.sup>xxviii, xxix, xxx/sup> /p> p classp2_content stylez-index: 1;>Asthma with underlying type 2 inflammation isbr classbreak_only> also known as type 2 asthma. sup>xxxi/sup>/p> /div> div classcomorbidities_content dummy_inflamfour slide_common scroll_common com_content> p classp2_content stylez-index: 1;> Type 2 inflammation can be a cause ofbr classbreak_only> other conditions throughout the bodybr classbreak_only> (known as comorbidities), such as allergicbr classbreak_only> rhinitis and nasal polyps.sup>xxiii/sup> br classbreak_only> /p> p classp2_content stylez-index: 1;>This explains why many people with type 2 br classbreak_only>inflammation may struggle with one orbr classbreak_only> more of these conditions in addition tobr classbreak_only> asthma./p> /div> div classnav_common_blu arr_new_com> div classowl-prev-ast btn_nav_arr enable>img alt src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/blue-arrow-left classprev_btn_blu>/div> div classowl-next-ast btn_nav_arr enable>img alt src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/blue-arrow-right classnext_btn_blu>/div> /div> div classdummy_type2 dum_com> ul classdummy_lt inflam_com dot_com_parent> li iddummy_inflamone classfirst_one dot_com inflam_com dummy_col stylez-index: 1;>/li> li iddummy_inflamtwo classinflam_com dot_com second_one stylez-index: 1;>/li> li iddummy_inflamthree classinflam_com dot_com third_one stylez-index: 1;>/li> li iddummy_inflamfour classinflam_com dot_com four_one stylez-index: 1;>/li> /ul> /div> /div> /div> div classfuture_care_wrap future_full side_three new_science_full> div classfuture_left future_full left_wrap_common> img classfuture_of_care gif_new_common visible-lg visible-md src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop - gif files/tnb_fourgoalsofasthmacontrol_v1> img classfuture_of_care gif_new_common visible-xs visible-sm src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/mobile- gif files/tnb_whatistype2inflammation_v1_mobile> /div> div classfuture_right future_full future_common right_wrap_common> div classtop_head> h3 stylez-index: 1;>FUTURE OF CARE /h3> div classnew_sci_social soc_common> div>a hrefhttps://twitter.com/search?q%23TheNextBreath stylecolor: #00aeef; font-size: 14px;> Follow us on #TheNextBreath/a> /div> /div> /div> div classfuture_slide_one slide_common dummy_futone future_common scroll_common active> p classp2_content stylez-index: 1;> Scientists are currently researching ways ofbr> reducing type 2 inflammation as much asbr> possible, with the goal of helping people achieve br>the four key measures of asthma control:sup>xii/sup> /p> ul typecircle> li stylez-index: 1;>strong>Preventing asthma attacks/strong>/li> li stylez-index: 1;>strong>Reducing symptoms to improve quality of life/strong>/li> li stylez-index: 1;>strong>Reducing the use of oral steroid medicines/strong>/li> li stylez-index: 1;>strong>Improving breathing (or “lung function”)/strong> /li> /ul> /div> div classfuture_slide_two slide_common dummy_futtwo future_common scroll_common> p classp2_content stylez-index: 1;> With the latest science opening up new possibilities, br classbreak_only>it’s time for a new conversation about the different br classbreak_only>types of asthma and the different ways in which itbr classbreak_only> can be managed. /p> a classbtn_content back_one hrefi-have-asthma target_blank>I HAVE ASTHMA OR HAVE A LOVED ONE WHO DOES/a> !-- a classbtn_content back_two href/i-treat-asthma target_blank> I TREAT ASTHMA/a> --> /div> div classnav_common_fut arr_new_com> div classowl-prev-ast btn_nav_arr enable>img alt src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/blue-arrow-left classprev_btn_blu>/div> div classowl-next-ast btn_nav_arr enable>img alt src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/blue-arrow-right classnext_btn_blu>/div> /div> div classdummy_fut dum_com> ul classdummy_future cir_fut dot_com_parent> li iddummy_futone classcir_fut dot_com first_one dummy_col stylez-index: 1;>/li> li iddummy_futtwo classcir_fut dot_com second_one stylez-index: 1;>/li> /ul> /div> /div> /div> /div> /div> div classsci_back_wrap> div classsci_back_content> div classsci_back_heading> h2 stylez-index: 1;>Are you a healthcarebr classbreak_only> provider who treatsbr classbreak_only> people with asthma?/h2> /div> div classback_para> p classp2_content stylez-index: 1;>Click here to learn more about the latest sciencebr classbreak_only> and treatment of type 2 inflammation. /p> a hrefhttps://www.understandingtype2inflammation.ca/ classbtn_content visible-lg visible-md target_blank>LEARN MORE/a> a hrefhttps://www.understandingtype2inflammation.ca/ classbtn_content visible-sm visible-xs target_blank>LEARN MORE/a> /div> /div> /div> /div> /div> /div> /div> /div> /div> /div> div classscore-container> div classcontainer> div classscore-page score-column1> div classscore-main> div classscore-inner> div classtext-component> div classget_involved idGet-started> div classget_involved_wrap> div classget_involved_content> h2 stylez-index: 1;>Moving the future of asthma forward, together/h2> /div> div classp2_content> p classp2_content stylez-index: 1;>Working together, we can bring more awareness to strong>severe asthma,/strong>br classbreak_only> illuminate the strong>latest science/strong> and strong> empower people to take action/strong> br classbreak_only>to strive for better asthma control. /p> /div> div classp2_content> p classp2_content stylez-index: 1;>Start using your next breath today to inspire others to get informed andbr classbreak_only> check back soon to find more ways to get involved./p> /div> div classhashtag_content> div> a hrefhttps://twitter.com/search?q%23TheNextBreath> h1 classhashtag stylez-index: 1;> Follow us on #TheNextBreath/h1> /a> /div> /div> /div> /div> /div> /div> /div> /div> /div> /div> /div> footer> div classscore-footer-wrapper> div classscore-footer> div classscore-container Foot> div classcontainer> div classscore-page score-column1> div classscore-main> div classscore-inner> div classtext-component> div classwrap> div classcorp-logos> img altThe next breath logo src-/media/ems/conditions/genzyme/brands/dupixent-uae/the-next-breath-logo.png@laen-gb&hash76b45a55d62c19c8235c23345af30c77ca2f12ac> /div> div classmobile> div classmob-logo> img alt classvisible-sm visible-xs logo-image-mobile src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/mobile-homepage/tnb-logo.png@laen-gb&hash358051e16b84f10291a65e43b53a0e728506c406> /div> /div> div classlink-wrap> div classcont> p>span classNextBrth>The Next Breath/span> is an initiative of Sanofi Global. Copyright strong>©/strong>2019 Sanofi Global Inc, – All rights reserved. Sanofi is a registered trademarks. /p> div classfooter-mat-code> p>MAT-AE-2300275/V1/April-2023/p> /div> p>This website is intended for United Arab Emirates only/p> p>Advertisement License No: DUINUQDZ-310323./p> !-- p>MD3A1QAU-010920/p> --> !-- div idFooter_lastupdate>/div> --> !-- div idFooter_jobcode> /div> --> /div> div classlogo> a classsanofi_icon_foot target_blank> img altsanofi logo src/resources/img/sanofi_white.svg> /a> p stylemargin: -80px 0px 0px; color: white; font-size: 10px; font-family: Futura BT light; text-align: right;>To report any product technical complaints, kindly contact quality.greatergulf@sanofi.combr>SANOFI, Level 3, One JLT, Jumeirah Lake Towers (JLT), DMCC, PO Box 53899, Dubai, UAE | Tel.: +971 4 550 3600 | Fax: +971 4 5521050br>For further medical information, Please contact: For UAE 800 MEDICAL Toll-Free Number,br>For all Gulf Countries +971 565776791 or email: medical-information.gulf@sanofi.combr>To report an adverse events please call: +971 561747001 or email: Gulf.Pharmacovigilance@sanofi.com /p> /div> /div> /div> /div> /div> /div> /div> /div> /div> div classscore-container> div classcontainer> div classscore-page score-column1> div classscore-main> div classscore-inner> div classtext-component> div classpopup_wrap> div classsymptoms_popup asthma_com> !--img alt src~\media\94F5A765-9B6D-4077-8E44-D5D2CDE1538E data-togglemodal data-target#symptom_myModal1 classsym_plus />--> /div> div idsymptom_myModal1 classmodal fade roledialog aria-hiddentrue> div classmodal-dialog common_modal> !-- Modal content--> div classmodal-content comon_con> div classmodal-header> !--button typebutton classclose data-dismissmodal>img alt src~\media\1FF290ED-4D47-44D5-B979-3062A6EAA19B>/button>--> button typebutton classclose data-dismissmodal>img alt src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop-homepage/close-button.png@laen-gb&hash92128716e38ce78fbea7d3900b9fad6822e16503>/button> /div> div classsymptom_modal-body> h2>References/h2> div classreference idstyle-3> ol> li>GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017:5;691-706./li> li>Parikh P. OPEN-ing up about asthma. Allergy & Asthma Today. 2016;14:22-23. Available at http://mydigimag.rrd.com/publication/?i326085#{“issue_id”:326085,”page”:20}. Last accessed November 2018/li> li>Price D, Fletcher M, van der Molen T. Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir Med. 2014;24:14009/li> li>Rabe, K. F., Vermeire, P. A., Soriano, J.B., Maier, W.C. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J. 2000;16:802-807./li> li>Fletcher M, Hiles D. Continuing discrepancy between patient perception of asthma control and real-world symptoms: a quantitative online survey of 1,083 adults with asthma from the UK. Prim Care Resp J. 2013;22(4):431-438/li> li>Murphy KR, et al. Asthma management and control in the United States: results of the 2009 Asthma Insight and Management survey. Allergy Asthma Proc. 2012 Jan-Feb;33(1):54-64/li> li>Andrews KL et al. Stigma: Still an Important Issue for Adults With Asthma. Journal of Asthma and Allergy Educators. Vol 4, Issue 4, 2013/li> li>Reddel HK, et al. Risks associated with managing asthma without a preventer: urgent healthcare, poor asthma control and over-the-counter reliever use in a cross-sectional population survey. BMJ Open. 2017;7:e016688. Available at: https://bmjopen.bmj.com/content/7/9/e016688.full?ijkeyJWTMTG1oSaXXktC&keytyperef/li> li>Bülow AV, et al. The Prevalence of Severe Asthma and Low Asthma Control Among Danish Adults. J Allergy Clin Immunol. 2014;2(6):759-767/li> li>Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. 2018. Available at: http://ginasthma.org/download/832/. Last accessed April 2018/li> li>Price D, Fletcher M, van der Molen T. Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey. NPJ Prim Care Respir Med. 2014;24:14009/li> li>Global Initiative for Asthma (GINA). Pocket Guide for Asthma Management and Prevention. 2018. Available at: https://ginasthma.org/2018-pocket-guide-for-asthma-management-and-prevention/. Last Accessed October 2018/li> li>Juniper EF, GH Guyatt, PJ Ferrie, et al. Measuring Quality of Life in Asthma. Am Rev Respir Dis. 1993;147:832-8./li> li>Asthma and Allergy Foundation of America. My Life with Asthma Survey Overview. Available at: http://www.aafa.org/media/1684/my-life-with-asthma-in-2017-survey-findings-report.pdf. Last accessed October 2018/li> li>Rand C, et al. Mediators of asthma outcomes. J Allergy Clin Immunol. 2012:129(3);136-141/li> li>Asthma and Allergy Foundation of America. My Life with Asthma Report. Available at http://www.aafa.org/my-life-with-asthma-report/. Last accessed October 2018/li> li>The European Academy of Allergy and Clinical Immunology (EAACI). Advocacy Manifesto: Tackling the Allergy Crisis in Europe - Concerted Policy Action Needed. Available at: http://www.eaaci.org/documents/EAACI_Advocacy_Manifesto.pdf. Last accessed October 2018/li> li>Behmanesh F, et al. Evaluation of anxiety and depression in mothers of children with asthma. Electron Physician. 2017:9(12);6058-6062/li> li>European Respiratory Society. European Lung White Book, Chapter 2: The economic burden of lung disease. Available at: http://www.erswhitebook.org/files/public/Chapters/02_economics.pdf. Last accessed October 2018/li> li>Daugherty J, et al. The impact of long-term systemic glucocorticoid use in severe asthma: A UK retrospective cohort analysis. J Asthma. 2017 Sep;19:1-8/li> li>Nunes C, Pereira AM, Morais-Ameida M. Asthma costs and social impact. Asthma Res Pract. 2017;3:1/li> li>Chipps et al. Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. J Allergy Clin Immunol. 2012 Aug;130(2):332-42./li> li>Gandhi NA, Bennett BL, Graham NM, et al. Targeting key proximal drivers of type 2 inflammation in disease. Nat Rev Drug Discov 2016;15(1):35-50/li> li>Woodruff PG, et al. T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma. Am J Respir Crit Care Med. 2009;180(5):388–395/li> li>Peters MC, Mekonnen ZK, Yuan S, et al. Measure of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma. J Allergy Clin Immunol. 2014;133(2):388-394/li> li>Fahy et al. Type 2 inflammation in asthma--present in most, absent in many. Nat Rev Immunol. 2015 Jan;15(1):57-65./li> li>Dunican EM, Fahy JV. The Role of type 2 inflammation in the pathogenesis of asthma exacerbations. Ann Am Thorac Soc.2015;12 Suppl 2:S144–S149/li> li>Muraro A, Lemanske RF, Hellings PW, et al. Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2016;137(5):1347-58/li> li>Ray A, Oriss TB, Wenzel SE. Emerging molecular phenotypes of asthma. Am J Physiol Lung Cell Mol Physiol. 2015;308(2):L130-40/li> li>Matsusaka M, K Fukunaga, H Kabata, et al. Subphenotypes of type 2 severe asthma in adults. J Allergy Clin Immunol Pract 2018;6(1):274-276.e2/li> li>Robinson D, Humbert M, Buhl R, et al. Revisiting type 2-high and type 2-low airway inflammation in asthma: current knowledge and therapeutic implications. Clin Exp Allergy. 2017: 47(2): 161-175. /li> li>Partridge, M. R. Delivering optimal care to the person with asthma: what are the key components and what do we mean by patient education? Eur Respir J. 1995: 8: 298-305./li> li>Asthma Society of Canada. Severe Asthma - The Canadian Patient Journey: A study of the personal, social, medical and economic burden of Severe Asthma in Canada. Available at: https://www.asthma.ca/wp-content/uploads/2017/06/SAstudy.pdf Last accessed: December 2018. 1-8./li> /ol> /div> /div> !--div classmodal-footer> div classsocial_content> button classbtn_content>a classanchor_content href>img alt classfacebook_logo src~/media/5736A1E6-6DF5-4F35-84C8-6B56424F94F8>Share on Facebook/a>/button> button classbtn_content>a classanchor_content href>img alt classtwitter_logo src~/media/4E02FDDB-0AB3-4927-8E3B-1A975DD58B5B>Share on Twitter/a>/button> /div> /div>--> /div> /div> /div> /div> /div> div classtext-component> div classpopup_wrap> div classsymptoms_popup asthma_com> img alt src~%255cmedia%255c897129e6-4513-4e05-9806-ecca604f6c37 data-togglemodal data-target#symptom_myModal2 classsym_plus> /div> div idsymptom_myModal2 classmodal fade roledialog aria-hiddentrue styledisplay: none;> div classmodal-dialog common_modal> !-- Modal content--> div idterms classmodal-content comon_con> div classmodal-header> button typebutton classclose data-dismissmodal>img alt src-/media/ems/conditions/genzyme/brands/dupixent-uae/dupi dsa - the next breath website/desktop-homepage/close-button.png@laen-gb&hash92128716e38ce78fbea7d3900b9fad6822e16503>/button> /div> div classsymptom_modal-body> h2>Privacy Policy and Legal Disclaimers/h2> div classLegal_notice idstyle-3> p>span classlegal-bold> Dear Visitor, br> The terms set out below comprise the legal conditions applying to each Internet user visiting this site (the Site). By using the Site you undertake to comply with these terms and conditions without reservation. We recommend that you regularly review these terms and conditions, as they may be modified from time to time without notice.br> We wish to emphasize that the Site, including all its content and all the information made available on it, is intended exclusively for residents of the United Arab Emirates. /span> /p> p> h3>1. Intellectual property/h3> p>The Site is owned and operated by Sanofi-Aventis Group (DMCC Branch) b>(Sanofi-Aventis)/b>. Sanofi-Aventis is part of the international Sanofi Group b>(Sanofi Group)/b>. All the materials and content published on the Site, including trademarks, logos and domain names displayed on it, are protected by applicable intellectual property laws and are owned by the Sanofi Group or its subsidiaries, including Sanofi-Aventis, or licensed to them./p> p>No material from the Site may be copied, reproduced, modified, republished, uploaded, distorted, transmitted or distributed in any way, in whole or in part, without the prior written consent of Sanofi-Aventis, except for media reporting purposes, provided that all intellectual property rights and other proprietary rights are respected. Copying is permitted solely for personal, noncommercial use./p> p>Any material or content copied from the Site must be accompanied by a notice that the copyright belongs and is reserved to Sanofi-Aventis, provided that any authorized use of visuals, whether constituting a component of the Site or included within it, does not lead to their distortion, modification or alteration in any way./p> p>The Sanofi Group and/or any of its subsidiaries, including Sanofi-Aventis, reserve the right to take legal action against any infringement of its intellectual property rights. /p> /p> p> h3>2.Privacy Policy/h3> p> 2.1 The following Privacy Policy (Privacy Policy), details the information gathering and dissemination practices of Sanofi-Aventis. /p> p> 2.2.The Privacy Policy outlines the types of information that Sanofi-Aventis gathers about individual visiting the Site, how Sanofi-Aventis collects and makes use of such information, including saving and sharing the information with third parties, etc. /p> p> 2.3.You are aware that information you provide Sanofi-Aventis as detailed below, may be stored in Sanofi-Aventis’s databases and that providing the Personal Information, as defined below is subject to your wish and your consent. /p> p>2.4.Sanofi-Aventis may store any information you provide to us (for example, if you contact us by telephone, email, this Site etc). Some of the information may include contact information (such as your name, address, email address and phone number) and any other information provided or made available to us by you b>(“Personal Information”)/b>. The information which does not identify you personally is not saved by us together with your Personal Information. Such a non-personal, aggregated statistical information is hereby referred to as Statistical Information. Examples of this type of information are: usage statistics, date and time you visited the Site, the pages you visited, the referrer (the website you came from), type of browser and operating system you are using, etc. (Personal Information and Statistical Information are collectively referred to herein as b>Information”/b>) /p> p>2.5.Sanofi-Aventis may use your Information – for one or more of the purposes detailed below: (i) for one or more of the purposes as detailed in these Terms of Use and Privacy Policy; (ii) contacting you directly in the event you report an adverse event; (iii) defending against legal proceedings; (iv) statistical analyzes; (v) to improve the Site, the products and our services; (vi) to enhance our marketing and to facilitate other business functions./p> /p> p>2.6.Sanofi-Aventis may share the Information with the following (i) service providers and vendors that assist Sanofi in providing Services such as IT service providers, legal advisers, etc; (ii) third parties in the event of any reorganization, merger, sale, joint venture, assignment, transfer or other disposition of all or any portion of Sanofi-Aventis’s business; (iii) other companies being members of Sanofi Group such as our affiliates, subsidiaries etc./p> p>2.7.Sanofi-Aventis may also disclose and share your Information as we believe to be necessary or appropriate: (i) to comply with applicable laws; (ii) to respond to requests from public and government authorities; (iii) to enforce Privacy Policy and Legal Disclaimers; (iv) to protect the rights, privacy, safety or property of Sanofi-Aventis, of you or of other third party;(v) in any dispute, claim, demand, law suit or proceedings whatsoever, whether between you or anyone acting on your behalf, and Sanofi-Aventis or anyone acting on its behalf./p> p>2.8.Please note that the Information may be transferred to other countries. The privacy and data protection laws in such countries may not have the same privacy and data protection laws as in the United Arab Emirates. By using the Site or providing Sanofi-Aventis with your Personal Information, you consent to the collection, storage (including in cloud), processing and transfer of Information as provided in these Terms of Use and Privacy Policy. /p> p>2.9.Sanofi-Aventis will retain your Information for the period necessary to fulfill the purposes outlined in this Privacy Policy, unless a longer retention period is permitted or required by law to fulfill the purposes./p> p>2.10.Cookies – A cookie is a file that is placed on the users hard disk by a web server, without causing any harm. It enables collecting statistical information about the users browsing habits, in order to ascertain his/her preferences and needs. The Site may place cookies on your computer and collect data about your activities on the site, your preferences and selections. These cookies will be used for statistical purposes of the Site,. Please note that most Internet browsers are set to enable cookies automatically, but it is generally possible to change the browser settings to disable cookies. If you choose to disable cookies, you might not be able to fully enjoy the Sites features and services, since some of the applications on the Site will quite possibly not function properly on a computer on which cookies have been blocked. /p> p>2.11.Sanofi-Aventis may use various tools for statistical analysis, research including Google Analytics which collects statistical and non-identifying information. Please note that without derogating from the above, the use of the Site is subject to Google Analytics’ Terms of Use and Privacy Policy. For more information regarding the privacy practices of Google Analytics, please visit Google Privacy & Terms web page: https://policies.google.com/technologies/partner-sites./p> p>2.12.Sanofi-Aventis may also track your usage of the site through the use of pixel tags. A pixel tag is a tiny graphic on a web page that is used to track pages viewed. Pixel tags may collect information such as the IP address and browser type related to the visitors computer. Pixel tags may be placed on online advertisements and on different pages of our sites. Pixel tags provide Sanofi-Aventis with information on how many times a page in the Site is opened and which information is consulted./p> p>2.13.Sanofi-Aventis may also automatically collect and store web log information relating to your computer and your visit, such as the name of the domain and host from which you access the Internet; the Internet address of the website from which you linked to the Site; the date and time you accessed the Site, how long you spent and which pages you visited; your computers operating system and browser software; and your Internet protocol (IP) address. If you have a static IP address, it is possible that this address could be used in combination with other information to identify you./p> p>2.14.Sanofi-Aventis takes reasonable technical and organizational measures designed to secure your Information from accidental loss and from unauthorized access, use, alteration or disclosure. However, due to the nature of the Internet, Sanofi-Aventis cannot guarantee that unauthorized third parties will never be able to overcome those measures or use your Information for improper purposes. /p> p>2.15.In accordance with the applicable laws relating to privacy protection, you have the right to review, modify and correct your Personal Information stored by Sanofi-Aventis. To exercise this right, simply write to us at the following address:/p> p>2.15.1.Online: (engage.gulf@sanofi.com) /p> p>2.15.2.By mail: Sanofi, Level 3, One JLT, Jumeirah Lake Towers (JLT), DMCC, PO Box 53899, Dubai, UAE /p> h3>3.Nature of information provided at the Site/h3> p> Expert opinions concerning subject areas related to the content of the Site and extracts from press articles may be posted on the Site, as relevant. Such information represents the opinion or position of the respective expert or newspaper and is not necessarily the opinion or position of Sanofi-Aventis or any of the companies in the Sanofi Group. The Sanofi Group is not responsible for the accuracy or completeness of any information or opinion set forth in such materials. Expert advice of this sort reflects only the personal view of that expert, and in no case shall it be regarded as the opinion or responsibility of the Sanofi Group. /p> p> The Site may also contain information relating to health, fitness, medical issues and types of medical therapy intended exclusively for human use. This material is made available for information purposes only and is not meant to replace advice provided by your own physician or pharmacist. You should not use the information contained on the Site for diagnosing any illness or physical condition or to prescribe or use any medication presented on the Site. You should always consult with your own physician. /p> h3>4.Pharmaceutical products and Side Effects/h3> p>4.1.The Site is not intended to discuss the side effects associated with the use of drugs or treatments of the Sanofi Group or third-parties, whether actual or potential./p> p>4.2 The Site is not intended to report side effects associated with the use of drugs. If you or someone you know, have met a potential side effect using a Sanofi-Aventis product, please send an email to the office of Sanofi-Aventis indicating the name of the product concerned and describing the side effects suffered. You can contact Sanofi–Aventis PV department via email: a hrefmailto: Gulf.pharmacovigilance@sanofi.com>Gulf.pharmacovigilance@sanofi.com/a>/p> h3>5.Links to Other Sites/h3> p>The Sanofi Group, including Sanofi-Aventis, disclaims all and any liability in relation to any third party site that was accessed via the Site. We have no control over the content of third party sites, which are and shall remain completely independent of the Sanofi Group. Moreover, the existence per se of a link between the Site and a third party site in no way implies that the Sanofi Group in any way approves the content of that site or any use to which such content may be put. External sites may contain hyperlinks leading to the Site. Such hyperlinks may not be installed without the express prior consent of Sanofi-Aventis. Sanofi-Aventis is in no way responsible for the unavailability of such external sites, and Sanofi-Aventis does not review, control or approve, nor is it responsible for, any content, advertising, products or other materials available on or accessible via those sites. It is your responsibility to take the necessary precautions to prevent the Site from being infected by any one or more computer viruses, Trojan horses or other malware./p> h3>6.Limitations of Liability/h3> p> Sanofi-Aventis makes every effort to ensure, to the best of its ability, that the information made available on the Site is accurate and up to date, and it reserves the right to change the content of the information at any time without notice. Nonetheless, Sanofi-Aventis cannot guarantee the accuracy or comprehensiveness of such information or the frequency in which it is updated. Therefore, and with the exception of direct damage resulting from willful misconduct or gross negligence by Sanofi-Aventis, Sanofi-Aventis disclaims liability for: /p> ul> li>any imprecision, inaccuracy or omission in the information made available on the Site;/li> li>any conclusion reached and/or any omission or action made based on the information that may be available on the Site;/li> li>any damage resulting from fraudulent intrusion by a third party leading to the modification of information or materials made available on the Site;/li> li>Any direct or indirect damage, regardless of its cause, origin, nature or consequences, resulting from (i) access or inability to access the Site (ii) the use of the Site, including any bug or virus that may infect your computer system or any other product; (iii) use of cookies and tools for statistical analysis and research as detailed above/li> /ul> p>The materials and content on the Site are made available as is, without any warranty of any kind, whether explicit or implied. Sanofi-Aventis does not offer any explicit or implied warranty of commercial quality or suitability for a particular purpose./p> h3>7.Availability of the Website/h3> p>By using the Site you acknowledge that (i) it is technically impossible for the Site to be provided free of defects and that Sanofi-Aventis cannot assume any responsibility for this; (ii) defects may lead to the Site being temporarily unavailable; and (iii) the operation of the Site may be adversely affected by external conditions and parameters outside the control of Sanofi-Aventis, such as transmission and telecommunication links between Sanofi-Aventis and you and between Sanofi-Aventis and other systems and networks./p> p>Sanofi-Aventis and/or its suppliers may, at any time, temporarily or permanently, modify or interrupt the operation of the Site, wholly or partly, in order to perform maintenance work and/or make changes and/or improvements to the Site. Sanofi-Aventis shall not be held liable for any modification, suspension or interruption in the operation of the Site./p> p>b>Information on Programs and Services The information/b> included and published on the Site may contain direct or indirect references to, programs and services of the Sanofi Group which are not offered or available in certain countries or regions or which may be offered under different trademarks, and which may be subject to different regulatory requirements and conditions of use according to the country. Such references do not imply any intention on the part of the Sanofi Group to provide these, programs or services in your country. Please consult Sanofi-Aventis for any information concerning the programs and services which are available in the United Arab Emirates./p> h3>8.Legal Framework/h3> p>The Site and its content shall be governed by the laws of the United Arab Emirates only. Any claim arising in connection with this Site and its content shall be conducted before the competent courts in Dubai./p> /div> /div> !--div classmodal-footer> div classsocial_content> button classbtn_content>a classanchor_content href>img alt classfacebook_logo src~/media/C8451284-DAD2-4D50-A3A7-C6DFF87E2C2D>Share on Facebook/a>/button> button classbtn_content>a classanchor_content href>img alt classtwitter_logo src~/media/FE5A1596-52D8-44A2-B869-C4023F0E24F3>Share on Twitter/a>/button> /div> /div>--> /div> /div> /div> /div> /div> /div> /div> /div> /div> /div> !--//////////////////////// // - START - FOOTER SECTION /////////////////////////--> div classcontainer> div classrow> div classcol-xs-12> div idemsFooter> footer classfooter> div idindicationCopy> h2>/h2> p>/p> /div> div idquickLinks> ul classpage-links> /ul> /div> div idhcProCopy classhc-pro-copy> p>/p> /div> div idfootnoteCopy classfootnote> /div> div idcorpFooter> span classft-name bold>/span>br /> span classft-pNumber>/span>br /> !-- Render Corporate Footer links --> span classft-links> /span>br /> span classft-note bold>/span>br /> span classft-date> : /span> /div> /footer> /div> /div> /div> /div> !--////////////////////// // - END - FOOTER SECTION ///////////////////////--> !--//////////////////////////// // - START - GOOGLE ANALYTICS // ////////////////////////////////--> !--//////////////////////////// // - END - GOOGLE ANALYTICS // ////////////////////////////////--> /div> /div> /footer> script srchttps://players.brightcove.net/3845398857001/default_default/index.min.js>/script> script> $(body).attr(id, homepage); /script> script srchttps://players.brightcove.net/1719543778001/vttjs/dist/vtt.min.js>/script> script> var lang document.getElementsByTagName(html)0.getAttribute(lang); if (lang en-GB) { document.getElementsByTagName(nav)0.innerHTML div style\text-align: right;top: 15px;right: 15px;color: #ffffff;font-size: 10px;z-index: 100;position: absolute;\>This website is intended for Kuwait Residents only /div> + document.getElementsByTagName(nav)0.innerHTML; } else { document.getElementsByTagName(nav)0.innerHTML div style\text-align: right;top: 15px;right: 15px;color: #ffffff;font-size: 10px;z-index: 100;position: absolute;\>This website is intended for United Arab Emirates only /div> + document.getElementsByTagName(nav)0.innerHTML; } /script> !-- GA Video tracking script --> script typetext/javascript srcsitecore modules/web/mediaframework/js/analytics/brightcove-ga-plugin.js>/script> script typetext/javascript> /* var myPlayer; var total_videos$(.video-js).length; for (i 0; i total_videos; i++) { videojs(document.querySelectorAll(.video-js)i).on(loadstart,function(){ myPlayer this; console.log(mediainfo object: , myPlayer.mediainfo); myPlayer.ga(); }); } */ /script> !-- End GA Video tracking script --> script srcresources/js/site/fa4f300fe6cb42a3966a620815d66ea0.js>/script> script srcresources/js/page/81d6185a780e4dd4aa06e4931824d50c.js>/script> script languagejavascript typetext/javascript> $.ajaxPrefilter(function(options) { if (options.url /api/DynamicForm/SendFormData) { var FormID JSON.parse(decodeURIComponent(options.data)).FormID; if (FormID ! undefined) { console.log(options + FormID); if ($(#RequestTokenID- + FormID).length) { var token $(#RequestTokenID- + FormID).val(); options.beforeSend function(xhr) { xhr.setRequestHeader(FormSubmissionVerificationToken, token); } } } } }); /script> input idMediaFramework_ItemId nameMediaFramework_ItemId typehidden value81D6185A780E4DD4AA06E4931824D50C>/body>/html>
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]